経皮的冠動脈インターベンション後の大腿動脈止血と橈骨動脈止血器具の臨床転帰の比較:FERARI研究

FASTNER Christian; FASTNER Christian; BEHNES Michael; BEHNES Michael; UENSAL Melike; UENSAL Melike; EL-BATTRAWY Ibrahim; EL-BATTRAWY Ibrahim; ANSARI Uzair; ANSARI Uzair; MASHAYEKHI Kambis; HOFFMANN Ursula; HOFFMANN Ursula; LANG Siegfried; LANG Siegfried; KUSCHYK Juergen; KUSCHYK Juergen; BORGGREFE Martin; BORGGREFE Martin; AKIN Ibrahim; AKIN Ibrahim

文献

J-GLOBAL ID：201702243605641518 整理番号：17A0664184

経皮的冠動脈インターベンション後の大腿動脈止血と橈骨動脈止血器具の臨床転帰の比較:FERARI研究

Clinical outcomes of femoral closure compared to radial compression devices following percutaneous coronary intervention: the FERARI study

出版者サイト複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=17A0664184&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0664184&from=J-GLOBAL&jstjournalNo=X0101A") }}

著者 (21件)： , , , , , , , , , , , , , , , , , , , ,
資料名：
巻： 32 号： 5 ページ： 520-530 発行年： 2017年05月
JST資料番号： X0101A ISSN： 0910-8327 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

経皮的冠動脈インターベンション(PCI)後の,止血器具を使用...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0664184&from=J-GLOBAL&jstjournalNo=X0101A") }}

循環系疾患の外科療法 , 医療用品 , 術後処置・予後 , 手術

引用文献 (31件)：

Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW (2011) Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 4:654-664
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774-782
Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB 3rd, Ohman EM, Stone GW (2007) Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49:1362-1368
Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schuhlen H, Dirschinger J, Berger PB, Schomig A, Intracoronary S, Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 Trial I (2006) Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295:1531-1538
Moscucci M, Fox KA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, White K, Goldberg RJ (2003) Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24:1815-1823

, , , , , ,

前のページに戻る